Chris Rhodes

Title: Chris Rhodes: Innovator in Pharmaceutical Formulations

Introduction

Chris Rhodes is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceutical formulations, particularly through his innovative work at Aileron Therapeutics, Inc. His expertise lies in the development of aqueous pharmaceutical formulations that have the potential to treat various diseases and disorders.

Latest Patents

Rhodes holds a patent for "Peptidomimetic macrocycles and formulations thereof." This patent describes aqueous pharmaceutical formulations for parenteral administration that comprise peptidomimetic macrocycles or pharmaceutically acceptable salts. These macrocycles are designed to bind to MDM2 and/or MDMX proteins, which are crucial in the treatment of certain diseases. The patent highlights methods of treating diseases and disorders using these formulations, showcasing Rhodes' innovative approach to pharmaceutical science. He has 1 patent to his name.

Career Highlights

Throughout his career, Chris Rhodes has demonstrated a commitment to advancing pharmaceutical research. His work at Aileron Therapeutics, Inc. has positioned him as a key player in the development of novel therapeutic solutions. His contributions have the potential to impact the treatment landscape significantly.

Collaborations

Rhodes collaborates with talented individuals in his field, including David Allen Annis and Krzysztof Darlak. These partnerships enhance the innovative capacity of his work and contribute to the success of their projects.

Conclusion

Chris Rhodes is a distinguished inventor whose work in pharmaceutical formulations is paving the way for new treatment options. His innovative contributions and collaborations reflect his dedication to improving healthcare outcomes.